title: Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
authors.forename: M G
authors.initials: MG
authors.lastname: Torrioli
authors.forename: S
authors.initials: S
authors.lastname: Vernacotola
authors.forename: P
authors.initials: P
authors.lastname: Mariotti
authors.forename: E
authors.initials: E
authors.lastname: Bianchi
authors.forename: M
authors.initials: M
authors.lastname: Calvani
authors.forename: A
authors.initials: A
authors.lastname: De Gaetano
authors.forename: P
authors.initials: P
authors.lastname: Chiurazzi
authors.forename: G
authors.initials: G
authors.lastname: Neri
mesh_terms: D000108:Acetylcarnitine / Q000627:therapeutic use*; D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D004311:Double-Blind Method; D005600:Fragile X Syndrome / Q000150:complications*; D006801:Humans; D008297:Male; D018697:Nootropic Agents / Q000627:therapeutic use*; D013223:Statistics as Topic; D016896:Treatment Outcome
chemical_list: D018697:Nootropic Agents; D000108:Acetylcarnitine